Authors: Olsen, E Duvic, M Frankel, A Kim, Y Martin, A Vonderheid, E Jegasothy, B Wood, G Gordon, M Heald, P Oseroff, A Pinter-Brown, L Bowen, G Kuzel, T Fivenson, D Foss, F Glode, M Molina, A Knobler, E Stewart, S Cooper, K Stevens, S Craig, F Reuben, J Bacha, P Nichols, J

Citation: E. Olsen et al., Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma, J CL ONCOL, 19(2), 2001, pp. 376-388

Authors: Zhang, Q Raghunath, PN Vonderheid, E Odum, N Wasik, MA

Citation: Q. Zhang et al., Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter, AM J PATH, 157(4), 2000, pp. 1137-1146

Authors: Stevens, SR Bowen, GM Duvic, M King, LE Knobler, R Lim, HW Margolis, D Parry, EJ Rook, AH Stricklin, GP Suchin, KR Tharp, MD Vonderheid, E Zic, JA

Citation: Sr. Stevens et al., Effectiveness of photopheresis in Sezary syndrome, ARCH DERMAT, 135(8), 1999, pp. 995-996